| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | ADAMTS19 |
| Uniprot No | Q8TE59 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-1207aa |
| 氨基酸序列 | MRLTHICCCCLLYQLGFLSNGIVSELQFAPDREEWEVVFPALWRREPVDPAGGSGGSADPGWVRGVGGGGSARAQAAGSSREVRSVAPVPLEEPVEGRSESRLRPPPPSEGEEDEELESQELPRGSSGAAALSPGAPASWQPPPPPQPPPSPPPAQHAEPDGDEVLLRIPAFSRDLYLLLRRDGRFLAPRFAVEQRPNPGPGPTGAASAPQPPAPPDAGCFYTGAVLRHPGSLASFSTCGGGLMGFIQLNEDFIFIEPLNDTMAITGHPHRVYRQKRSMEEKVTEKSALHSHYCGIISDKGRPRSRKIAESGRGKRYSYKLPQEYNIETVVVADPAMVSYHGADAARRFILTILNMVFNLFQHKSLSVQVNLRVIKLILLHETPPELYIGHHGEKMLESFCKWQHEEFGKKNDIHLEMSTNWGEDMTSVDAAILITRKDFCVHKDEPCDTVGIAYLSGMCSEKRKCIIAEDNGLNLAFTIAHEMGHNMGINHDNDHPSCADGLHIMSGEWIKGQNLGDVSWSRCSKEDLERFLRSKASNCLLQTNPQSVNSVMVPSKLPGMTYTADEQCQILFGPLASFCQEMQHVICTGLWCKVEGEKECRTKLDPPMDGTDCDLGKWCKAGECTSRTSAPEHLAGEWSLWSPCSRTCSAGISSRERKCPGLDSEARDCNGPRKQYRICENPPCPAGLPGFRDWQCQAYSVRTSSPKHILQWQAVLDEEKPCALFCSPVGKEQPILLSEKVMDGTSCGYQGLDICANGRCQKVGCDGLLGSLAREDHCGVCNGNGKSCKIIKGDFNHTRGAGYVEVLVIPAGARRIKVVEEKPAHSYLALRDAGKQSINSDWKIEHSGAFNLAGTTVHYVRRGLWEKISAKGPTTAPLHLLVLLFQDQNYGLHYEYTIPSDPLPENQSSKAPEPLFMWTHTSWEDCDATCGGGERKTTVSCTKIMSKNISIVDNEKCKYLTKPEPQIRKCNEQPCQTRWMMTEWTPCSRTCGKGMQSRQVACTQQLSNGTLIRARERDCIGPKPASAQRCEGQDCMTVWEAGVWSECSVKCGKGIRHRTVRCTNPRKKCVLSTRPREAEDCEDYSKCYVWRMGDWSKCSITCGKGMQSRVIQCMHKITGRHGNECFSSEKPAAYRPCHLQPCNEKINVNTITSPRLAALTFKCLGDQWPVYCRVIREKNLCQDMRWYQRCCETCRDFYAQKLQQKS |
| 预测分子量 | 134 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于ADAMTS19重组蛋白的参考文献示例(注：部分文献信息为示例性虚构，实际研究中请核实真实文献)：
1. **文献名称**: *"Recombinant ADAMTS19 Protease Activity in Collagen Remodeling"*
**作者**: Smith J, et al.
**摘要**: 本研究成功在大肠杆菌中表达并纯化了重组ADAMTS19蛋白，证实其具有切割Ⅳ型胶原的活性，提示其在细胞外基质重塑中的潜在作用。
2. **文献名称**: *"ADAMTS19 Recombinant Protein Attenuates TGF-β Signaling in Fibrotic Models"*
**作者**: Lee H, et al.
**摘要**: 通过哺乳动物细胞系统表达ADAMTS19重组蛋白，发现其通过调控TGF-β通路抑制成纤维细胞活化，为纤维化疾病治疗提供新靶点。
3. **文献名称**: *"Structural and Functional Characterization of ADAMTS19 Catalytic Domain"*
**作者**: Gonzalez R, et al.
**摘要**: 解析了ADAMTS19重组蛋白催化结构域的晶体结构，揭示其底物结合特异性，并验证其金属蛋白酶活性依赖Zn²⁺离子。
4. **文献名称**: *"ADAMTS19 Deficiency and Recombinant Protein Rescue in Zebrafish Development"*
**作者**: Wang Y, et al.
**摘要**: 利用斑马鱼模型证明ADAMTS19基因敲除导致心脏发育缺陷，注射重组ADAMTS19蛋白可部分恢复表型，强调其在胚胎发育中的功能。
**提示**：实际文献可通过PubMed、Web of Science等平台以关键词“ADAMTS19 recombinant”或“ADAMTS19 expression”检索，部分研究可能聚焦于该蛋白的基因功能或疾病关联，需筛选涉及重组蛋白制备的内容。
ADAMTS19 (A Disintegrin and Metalloproteinase with Thrombospondin Motifs 19) is a member of the ADAMTS family of secreted zinc-dependent proteases, which play critical roles in extracellular matrix (ECM) remodeling, tissue development, and cellular signaling. This protein shares the conserved domain architecture of ADAMTS proteases, including a prodomain, metalloproteinase domain, disintegrin-like domain, thrombospondin type-1 (TSP1) motifs, and a cysteine-rich region. While less characterized compared to other ADAMTS members (e.g., ADAMTS1. ADAMTS13), emerging studies suggest ADAMTS19 may participate in cardiovascular development, skeletal homeostasis, and fibrotic processes. Genetic variants in ADAMTS19 have been tentatively linked to connective tissue disorders and osteoarthritis, though its precise physiological and pathological mechanisms remain unclear.
Recombinant ADAMTS19 protein, typically produced in mammalian expression systems (e.g., HEK293 or CHO cells), enables functional studies by providing a purified, bioactive form of the enzyme. Its production often involves truncating the C-terminal ancillary domains to enhance solubility while retaining catalytic activity. Researchers utilize this recombinant protein to investigate substrate specificity, enzymatic regulation, and interactions with ECM components like proteoglycans or collagen networks. Current applications include in vitro models of tissue fibrosis, angiogenesis assays, and mechanistic studies in developmental biology. As therapeutic targeting of metalloproteinases carries clinical relevance in cancer and degenerative diseases, characterizing ADAMTS19's biological functions through recombinant protein tools could uncover novel pathways for drug development. However, challenges persist in identifying endogenous substrates and reconciling in vitro findings with in vivo knockout phenotypes.
×
